WallStSmart
ALKS

Alkermes Plc

NASDAQ: ALKS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$33.71
-1.26% today

Updated 2026-04-29

Market cap
$5.62B
P/E ratio
23.57
P/S ratio
3.81x
EPS (TTM)
$1.43
Dividend yield
52W range
$25 – $36
Volume
2.4M

Alkermes Plc (ALKS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$83.73M$42.42M$34.59M$-12.25M$-5.91M$-2.48M$126.55M$92.20M$11.14M$-40.36M$-63.80M$19.19M$99.28M$72.08M$82.84M$101.72M$21.04M$401.35M$439.12M$520.75M
Capital expenditures$36.30M$21.89M$5.50M$15.79M$9.40M$16.99M$22.22M$19.05M$33.65M$52.88M$43.66M$51.30M$69.43M$90.94M$42.22M$29.02M$38.26M$48.05M$33.48M$40.42M
Depreciation$11.99M$12.14M$10.27M$25.03M$8.65M$93.68M$73.75M$70.80M$98.09M$85.60M$94.26M$98.52M$103.66M$80.41M$81.85M$78.65M$77.86M$74.93M$28.53M
Stock-based comp$14.81M$13.92M$28.83M$28.83M$41.29M$59.58M$97.34M$94.40M$83.92M$105.36M$100.98M$90.16M$87.62M$94.25M$100.91M$96.64M$98.72M
Free cash flow$47.42M$20.53M$29.09M$-28.03M$-15.31M$-19.47M$104.33M$73.15M$-22.51M$-93.24M$-107.46M$-32.11M$29.85M$-18.86M$40.62M$72.69M$-17.21M$353.31M$405.64M$480.33M
Investing cash flow$-30.08M$61.97M$45.36M$28.01M$5.63M$-417.16M$-68.15M$-177.19M$-263.40M$-43.49M$127.24M$-18.36M$-22.20M$-141.83M$-11.48M$-66.20M$-64.54M$53.36M$-111.31M
Financing cash flow$-6.73M$-83.65M$-94.30M$-23.33M$-40.65M$464.85M$-45.04M$43.70M$308.76M$40.89M$-58.17M$4.08M$-1.62M$6.76M$-2.17M$29.07M$-1.57M$-289.71M$-494.14M
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$9.61M$671999.00$8.75M$1.43M
Share repurchases
Debt repayment
Net change in cash$45.21M$13.36M$56.50M$-42.95M$5.27M$4.92M$75.47M$-62.99M$69.19M$64.58M$-45.07M